In Section A, members will acquire various doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental participants might be enrolled at the recognized monotherapy dosign routine. In Segment B, individuals will obtain oral ruxolitinib and ABBV-744 are going to be offered as "incorporate-on" therapy. In Section https://landengtgtg.fare-blog.com/32204128/detailed-notes-on-abbv-744-brd4-inhibitor-mechanism-of-action